↓ Skip to main content

Targeting Histone Deacetylases: Opportunities for Cancer Treatment and Chemoprevention

Overview of attention for article published in Pharmaceutics, January 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (86th percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news
1 news outlet
wikipedia
1 Wikipedia page

Citations

dimensions_citation
29 Dimensions

Readers on

mendeley
40 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Targeting Histone Deacetylases: Opportunities for Cancer Treatment and Chemoprevention
Published in
Pharmaceutics, January 2022
DOI 10.3390/pharmaceutics14010209
Pubmed ID
Authors

Dusan Ruzic, Nemanja Djoković, Tatjana Srdić-Rajić, Cesar Echeverria, Katarina Nikolic, Juan F. Santibanez

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 40 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 40 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 6 15%
Other 3 8%
Researcher 3 8%
Student > Master 3 8%
Student > Postgraduate 3 8%
Other 3 8%
Unknown 19 48%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 7 18%
Medicine and Dentistry 5 13%
Pharmacology, Toxicology and Pharmaceutical Science 3 8%
Chemistry 2 5%
Environmental Science 1 3%
Other 4 10%
Unknown 18 45%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 February 2023.
All research outputs
#2,779,190
of 23,306,612 outputs
Outputs from Pharmaceutics
#212
of 5,420 outputs
Outputs of similar age
#68,051
of 505,692 outputs
Outputs of similar age from Pharmaceutics
#20
of 450 outputs
Altmetric has tracked 23,306,612 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,420 research outputs from this source. They receive a mean Attention Score of 3.9. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 505,692 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 450 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.